{
    "clinical_study": {
        "@rank": "16607", 
        "acronym": "RDN-Cath-1", 
        "arm_group": [
            {
                "arm_group_label": "Renal denervation (RDN)", 
                "description": "Change of catecholamine spill-over during RDN"
            }, 
            {
                "arm_group_label": "Electrophysiology (EP) Ablation", 
                "description": "Change of catecholamine spill-over during EP ablation"
            }
        ], 
        "biospec_descr": {
            "textblock": "Blood for measurement of catecholamines."
        }, 
        "biospec_retention": "None Retained", 
        "brief_summary": {
            "textblock": "Despite a rapidly increasing number of renal denervation (RDN) procedures, only little is\n      known regarding the patient or procedural characteristics influencing the outcome. None of\n      the detectable variables like number of ablation points, temperature rise, impedance drop,\n      have been shown to correlate with the blood pressure (BP) reduction. In this study, the\n      investigators assess different patient and procedural characteristics, like exact patient\n      medication, stress hormones, heart rate variability, and focus on the change of the\n      catecholamine spill-over, and the impact on BP and heart rate after RDN and after EP\n      ablation. The investigators hypothesize the correlation between reduction of catecholamine\n      spill-over due to denervation and the BP reduction. In this study, the investigators will\n      assess 40 patients undergoing RDN and 40 patients undergoing EP ablation."
        }, 
        "brief_title": "Impact of Catecholamine Spill-over on Outcome After RDN and EP Ablation", 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  medically-indicated renal denervation\n\n          -  Age over 18 years\n\n          -  written informed consent\n\n        Exclusion Criteria:\n\n          -  pregnancy\n\n          -  expected compliance problems\n\n          -  current participation in other studies"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients undergoing renal denervation or EP Ablation with informed consent fulfilling all\n        inclusion criteria and None of the exclusion criteria."
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01875809", 
            "org_study_id": "RDN-Cathecholamines-1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "RDN", 
            "renal denervation", 
            "catecholamine", 
            "spill-over", 
            "blood pressure", 
            "electrophysiology", 
            "ablation"
        ], 
        "lastchanged_date": "June 11, 2013", 
        "link": {
            "description": "Description of the RDN procedure at our center", 
            "url": "http://www.helios-kliniken.de/klinik/wuppertal/fachabteilungen/herzzentrum/herzzentrum-wuppertal/kardiologie/leistungsspektrum/herzkatheterlabor.html"
        }, 
        "location": {
            "contact": {
                "email": "klaus.tiroch@helios-kliniken.de", 
                "last_name": "Klaus A Tiroch, MD", 
                "phone": "+49-202-896-5698"
            }, 
            "contact_backup": {
                "email": "jacek.szymanski@helios-kliniken.de", 
                "last_name": "Jacek Szymanski, MD", 
                "phone": "+49-202-896-5377"
            }, 
            "facility": {
                "address": {
                    "city": "Wuppertal", 
                    "country": "Germany", 
                    "state": "Nordrhein-Westfalen", 
                    "zip": "42117"
                }, 
                "name": "HELIOS Klinikum"
            }, 
            "investigator": [
                {
                    "last_name": "Klaus A Tiroch, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Marc Vorpahl, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jacek Szymanski, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Armin Sause, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Osman Tutdibi, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sebastian Winn, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Ina Schmitz, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "2", 
        "official_title": "Impact of Patient-specific and Procedural Characteristics Like Catecholamine Spill-over on the Long-term Outcome After Renal Denervation and EP Ablation", 
        "overall_contact": {
            "email": "klaus.tiroch@helios-kliniken.de", 
            "last_name": "Klaus A Tiroch, MD", 
            "phone": "+49-202-896-5698"
        }, 
        "overall_contact_backup": {
            "email": "jacek.szymanski@helios-kliniken.de", 
            "last_name": "Jacek Szymanski, MD", 
            "phone": "+49-202-896-5377"
        }, 
        "overall_official": {
            "affiliation": "University Wittn/Herdecke", 
            "last_name": "Klaus A Tiroch, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Measurement the differences of norepinephrine and epinephrine (pg/ml) in the renal vein and artery before and after the ablation", 
            "measure": "Catecholamine norepinephrine and epinephrine (pg/ml)", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "reference": [
            {
                "PMID": "21403086", 
                "citation": "Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011 May;57(5):911-7. doi: 10.1161/HYPERTENSIONAHA.110.163014. Epub 2011 Mar 14."
            }, 
            {
                "PMID": "21093036", 
                "citation": "Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, B\u00f6hm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010 Dec 4;376(9756):1903-9. doi: 10.1016/S0140-6736(10)62039-9. Epub 2010 Nov 17."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01875809"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Witten/Herdecke", 
            "investigator_full_name": "Tiroch, Klaus", 
            "investigator_title": "Privatdozent Dr. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "19710497", 
            "citation": "Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009 Aug 27;361(9):932-4. doi: 10.1056/NEJMc0904179."
        }, 
        "secondary_outcome": {
            "description": "Complete measurement of 24-hour systolic, diastolic, and mean arterial blood pressure (mmHg) and heart rate (beats/min)before and after ablation", 
            "measure": "Impact of the ablation on 24-hour blood pressure (mmHg) and heart rate (beats/min)", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "University of Witten/Herdecke", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Witten/Herdecke", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}